Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Doering

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Pageof 3